Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Pure Extracts (PULL) and Psyence Group (PSYG) have formed a JV for psychedelic medicinal mushroom extracts
  • The Pure Psyence partnership will develop naturally-derived psilocybin extracts and psilocybin formulations for the treatment of mental health
  • The companies are confident that their combined expertise will facilitate production on a commercial pharmaceutical scale
  • The Psyence Group uses natural psilocybin to treat psychological trauma and its mental health consequences
  • Pure Extracts is a plant-based extraction company based in Whistler, British Columbia
  • Psyence Group (PSYG) is unchanged trading at $0.20 per share
  • Pure Extracts (PULL) is down by 3.33 per cent trading at $0.29 per share

Pure Extracts (PULL) and Psyence Group (PSYG) have formed a JV for psychedelic medicinal mushroom extracts.

The Pure Psyence partnership will develop naturally-derived psilocybin extracts and psilocybin formulations for the treatment of mental health and psychological trauma.

The work will leverage Psyence’s in-house psilocybin mushrooms alongside Pure Extracts’ extraction expertise to reach production on a commercial pharmaceutical scale.

Psyence built and operates one of the world’s first federally licensed commercial psilocybin cultivation and production facilities. Located in the Kingdom of Lesotho, the facility was designed and constructed to The British Standards Institute and Good Manufacturing Practice standards.

Ben Nikolaevsky, Pure Extracts’ CEO, remarked,

“Pure Psyence sits at the intersection of evidence-based science and nature. The researchers, scientists and physicians at Pure Psyence will now be uniquely positioned to bring psilocybin whole mushroom in measurable pharmaceutical dosages to market.”

The Psyence Group uses natural psilocybin to treat psychological trauma and its mental health consequences.

Pure Extracts is a plant-based extraction company based in Whistler, British Columbia.

Psyence Group (PSYG) is unchanged trading at $0.20 per share as of 10:21 am ET.

Pure Extracts (PULL) is down by 3.33 per cent trading at $0.29 per share as of 10:01 am ET.

More From The Market Herald

" Andlauer Healthcare Group (TSX:AND) completes $169M bought deal offering

Andlauer Healthcare Group Inc. (AND) and Andlauer Management Group Inc. completed a bought deal offering of 3.5 million subordinate voting shares (SVSs).

" Avricore (TSXV:AVCR) expands HealthTab to select Shoppers Drug Mart locations in BC

Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC.

" Clearmind (CSE:CMND) signs development and supply agreement with Aragen Life Sciences

Clearmind Medicine (CMND) will work with Aragen Life Sciences to produce its innovative molecule, 5-Methoxy-2-aminoindane (MEAI).

" Aptose (TSX:APS) expands senior leadership team

Aptose Biosciences (TSX: APS) has appointed two key members to its management team to support its finance and operations functions.